Literature DB >> 1257697

Production and evaluation of high-quality thyroxine antisera for use in radioimmunoassay.

V Kruse.   

Abstract

High-quality thyroxine (T4) antisera were raised in rabbits. Conjugates of protein and T4 or T4 methyl ester were given intracutaneously in Freund's complete adjuvant at one or two sites on the back at 1/2- to 3-month intervals. Eleven of 16 immunized rabbits produced antiserum with titers higher than 2 commercial antisera and 4 antisera from other laboratories. All 16 antisera had equilibrium constants (K) higher than the 6 reference sera. The highest titer observed was 130,000 with 88 fmol labeled T4 per ml incubate. A drastic increase in K from about 4 X 10(8) to 5.8 X 10(10) 1/mol was observed as the immunization proceeded. Cross-reactivity with triiodothyronine (T3) varied but was generally low. Suppression of the T4 synthesis was attempted by giving 30 nmol (20 mug) T3 per os once a day. Antiserum from rabbits given T3 suppression contained less iodine than antiserum from nonsuppressed control rabbits. The possible reasons for the successful production of the high-quality antisera are discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1257697     DOI: 10.3109/00365517609068024

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  3 in total

1.  Milk antitrypsin activity during clinical and experimental bovine mastitis.

Authors:  T Honkanen-Buzalski; T Katila; M Sandholm
Journal:  Acta Vet Scand       Date:  1981       Impact factor: 1.695

2.  Total thyroxine and free thyroxine index in plasma of dairy cows in relation to strength of heat.

Authors:  O Andresen; J Amrud; L E Grøholt; G Helland; K A Schie; G A Sylliås
Journal:  Acta Vet Scand       Date:  1980       Impact factor: 1.695

3.  Thyroxine in blood plasma related to plasma levels of acetoacetate and glucose in ketotic and healthy cows.

Authors:  E Ropstad; K Halse; A O Refsdal
Journal:  Acta Vet Scand       Date:  1989       Impact factor: 1.695

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.